Topic

Articles

AI can also help reduce waste from 70% to 25%.

Shortening Clinical Drug Supply Timelines Using AI

Panel at SCOPE discusses the possibilities of research in a post-COVID world.






Global Health Crisis Provides Learning Opportunities Moving Forward 

Loftware VP - Lifesciences Product Management

Concept of flexibility acting as driving force behind industry’s swift response to COVID-19.

Clinical Trials Supply Chain: How to Respond to Recent Transformations 

VP Clinical Trials Global Sales, Loftware

How smart packaging can aid clinical trial adherence.

Putting Labeling on the Boardroom Agenda

COVID-19 provides unique opportunity for overhaul of logistics.

Moving into the Future of Clinical Trials

The success of the decentralized model hinges on coordination between stakeholders across the supply chain to ensure that date is secure, medication is delivered on time, and in proper condition.

Direct-to-Patient: At-Home Clinical Trials Are Here to Stay

Expectations for trial design will continue to change, and it’s critical that IRT vendors continue to listen to their customers and evolve their offerings accordingly.

Clinical Trials Are Changing—What Does This Mean For IRT?

The importance of examining this generation’s influence on the clinical trial value chain.

Millennials and their Impact on Clinical Research

Rolf Ehrhardt, MD, PhD is CEO of MedCision.

Automation will be key to improving efficiency and mitigating risk during the complex process of cell therapy production and delivery.

The Success of Cell Therapies Will Depend on Automation

Gaps in the good manufacturing practice controls on medicines for clinical trials are targeted in new rules from the EU.

Clinical Trial Supply Chain